跳至主要内容
临床试验/ITMCTR1900002416
ITMCTR1900002416尚未招募未知

Study for correlation between changes in stimulatory immune checkpoints of peripheral blood lymphocyte and efficacy before and after treatment with PD-1 for advanced NSCLC patients

Shanxi Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Basic Science

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • 1. Aged greater than or equal to 18 years;
  • 2. Histopathology is clearly diagnosed as NSCLC;
  • 3. Clinical stage is stage IV;
  • 4. ECOG score is 0 to 2 points;
  • 5. There are evaluable lesions.

排除标准

  • 1. There have been acute cardiogenic diseases or chronic basic diseases, which may interfere with treatment after evaluation;
  • 2. previous severe liver and kidney dysfunction;
  • 3. end stage, inability to tolerate PD-1 treatment;
  • 4. patients autoimmune system disease.

研究者

发起方
Shanxi Provincial Hospital of Traditional Chinese Medicine

相似试验